Prevalence of Endolymphatic Hydrops With a Hitory of Congenital Cytomegalovirus Infection
Reason given: The study was discontinued due to lack of inclusion.
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Trial details
- Who runs it
- Fondation Ophtalmologique Adolphe de Rothschild
- Trial code
- NCT05229744
- Record updated
- 6 January 2026
- Original description
The management of patients with a history of congenital CMV infection (whether symptomatic or asymptomatic at birth) is modeled on their usual management.Read full original descriptionShow less
Prevalence of Endolymphatic Hydrops in Patients With a History of Congenital Cytomegalovirus Infection With Symptomatic Cochleo-vestibular Involvement
The management of patients with a history of congenital CMV infection (whether symptomatic or asymptomatic at birth) is modeled on their usual management.
Inclusion: Patient over 6 months old; With a history of confirmed congenital CMV infection; Suffering from symptomatic cochleo-vestibular dysfunction (average hearing threshold> 20dB in at least one ear and / or abnormal functioning of one or more sectors at the vestibular level); For adult patients, having received informed information about the study and having signed a consent to participate in the study; For minor patients written consent of the two holders of the exercise of parental authority; Affiliate or beneficiary of a social security scheme.
Exclusion: Injection of gadolinium in the previous 7 days; Patient with a proven allergy to gadolinium; Known impairment of renal function ((estimated GFR <60 mL / min / 1.73 m²); Patient benefiting from a legal protection measure; Pregnant or breastfeeding woman; Contraindication to MRI (implanted electrical device, metallic foreign body, claustrophobia).